ALT uses emulsion technology to create flavor neutral, zero calorie, sugar-free, vegan, keto, and paleo friendly water-compatible medical cannabis products in the form of nanoemulsions, which are kinetically stable with a small particle size. ALT’s technology allows for more effective delivery of cannabinoids to the user, compared to tinctures and other ingestible products.
Patients will benefit from rapid onset within 5-15 minutes, in addition to higher efficiency in absorption of medical cannabis. ALT offers precise doses of cannabinoids based on their individual need for relief from an array of ailments. ALT’s products are designed to allow patients to titrate their dose accordingly.
“We are honored to partner with GROW in bringing ALT’s completely differentiated brand and liquid medical cannabis technologies to the European medical markets,” said ALT CEO Robert Davis. “After successfully launching ALT into California in December 2020, we are excited to expand internationally, our first step towards becoming a global brand. ALT’s mission is to Enhance Human Potential and we will do so, one patient at a time, through the power of our liquid cannabis platform.”
ALT plans to have a range of EU GMP-certified liquid medical cannabis products available for patients in Europe by early 2022. Medical patients will have access to ALT’s products by obtaining prescriptions through private practice or national health services.
“Grow’s mission is to bring medical cannabis products to all patients who need them,” said Grow Group CEO Ben Langley. “We strive to constantly improve and innovate on our product offering. With our leading position and unique experience we are very confident that with ALT’s new mode of administration, using liquid medical cannabis, we are going to make another leap forward in providing patients with the best products and solutions for their symptom management."
Bar Capital Global introduced and advised both ALT and Grow on this groundbreaking relationship and will continue to assist in the successful launch of the products.